American Portfolios Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

American Portfolios Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,408	Closed	-$462K	–	3355
2020 Q4	$462K	Sell	6,408 -196	-3%	-$10.3K	0.02%	584
2020 Q3	$301K	Buy	6,604 +223	+3%	+$9.32K	0.02%	653
2020 Q2	$288K	Buy	6,381 +58	+0.9%	+$2.6K	0.02%	612
2020 Q1	$243K	Buy	6,323 +782	+14%	+$36K	0.02%	587
2019 Q4	$257K	Buy	5,541 +1,144	+26%	+$49.5K	0.02%	654
2019 Q3	$179K	Buy	4,397 +24	+0.5%	+$1.04K	0.01%	752
2019 Q2	$211K	Buy	4,373 +2,320	+113%	+$122K	0.02%	697
2019 Q1	$129K	Buy	+2,053	New	+$141K	0.01%	783

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

American Portfolios Advisors's BEAT Position: Q1 2021 in Review

American Portfolios Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,408 shares — an estimated $462K sold.

American Portfolios Advisors first reported a position in BEAT in Q1 2019 and held it in 8 quarters. The position peaked at $462K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

American Portfolios Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
American Portfolios Advisors sold 6,408 BioTelemetry, Inc. shares in Q1 2021, an estimated $462K.
American Portfolios Advisors first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 8 quarters.
American Portfolios Advisors's BioTelemetry, Inc. position peaked at $462K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.